Physician

Thoracic Surgery

Reza J. Mehran, MD is an expert in the field of Thoracic Surgery. He received 1 awards: "Top Doctors:SE Texas". Reza Mehran is a published physician as well. He has 44 publications published. The latest was: Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. He is registered with Medicare and accepts Medicare payments.

Publications

---

• Survival in Patients With Esophageal AdenoCarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
• Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer.
• Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung Cancer surgery: a retrospective study.
• An update on clinicopathological, immunohistochemical, and molecular profiles of colloid Carcinoma of the lung.
• Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung Cancer.
• Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management.
• Is Complete Liver Resection Without Resection of Synchronous Lung Metastases Justified?
• Hemithoracic Intensity Modulated Radiation Therapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Toxicity, Patterns of Failure, and a Matched Sur...
• Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy.
• Impact of a Fast-Track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges.
• Simultaneous Lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and Lung metastases.
• Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung Cancer: how to fly in a "no fly zo...
• Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lun...
• Tumor endothelial markers define novel subsets of Cancer-specific circulating endothelial cells associated with antitumor efficacy.
• Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.
• Concordance of studies for nodal staging is prognostic for worse survival in esophageal Cancer.
• The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal AdenoCarcinoma.
• The role of surgery in patients with clinical n2 Disease.
• Visceral pleural invasion is not predictive of survival in patients with lung Cancer and smaller tumor size.
• Diaphragmatic Hernia After Esophagectomy in 440 Patients With Long-Term Follow-Up.
• Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
• Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer.
• Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal Cancer.
• Patients with high body mass index tend to have lower stage of esophageal Carcinoma at diagnosis.
• Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal AdenoCarcinoma.
• The prognostic factors of chest wall metastasis resection.
• The influence of high body mass index on the prognosis of patients with esophageal Cancer after surgery as primary therapy.
• Genetically abnormal circulating cells in lung Cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
• Association of age and survival in patients with gastroesophageal Cancer undergoing surgery with or without preoperative therapy.
• Impact of tumor length on long-term survival of pT1 esophageal adenoCarcinoma.
• Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
• Application of the revised lung Cancer staging system (IASLC Staging Project) to a Cancer center population.
• Management of primary pulmonary artery sarcomas.
• Esophageal tumor length is independently associated with long-term survival.
• Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung Cancer.
• 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
• Incidental finding of prostate Cancer and adenomatous colon polyp in a patient with lung Cancer.
• Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung Cancer.
• Case 5-2007 postoperative complications after pneumonectomy: clinical conference.
• Mucous membrane pemphigoid with fatal bronchial involvement in a seventeen-year-old girl.
• Intrathoracic leaks following esophagectomy are no longer associated with increased mortality.
• Insulin-like growth factor binding protein-2 level is increased in blood of lung Cancer patients and associated with poor survival.
• Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal Cancer.

Procedures Preformed

---

• Biopsy of Breast
• Decortication and Pleurectomy
• Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
• Embolectomy, Thrombectomy, or Vessel Exploration
• View All

Conditions Treated

---

• Abdominal Pain
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anorectal Abscess
• View All

Doctors Specialties

---

• General Surgery
• Thoracic Surgery

Accepted Insurances

---

Awards

---

• Top Doctors:SE Texas

Education

---

• McGill University Faculty of Medicine

Hospital

---

• University of Texas M.D. Anderson Cancer Center

Drug Facts

---

NPI NUMBER		1124123450
NPPES Provider LastName		MEHRAN
NPPES Provider FirstName		REZA
NPPES Provider ZIPCode		770304009
NPPES Provider State		TX
Specialty Description		Thoracic Surgery
Total Claim Count		137.0
Distinct Opioid Count		1.0
Opioid Claim Count		30.0
Percent Opioid Claims		21.9

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1124123450
Last Name Of The Provider	MEHRAN
First Name Of The Provider	REZA
View All

Similar Doctors

---

	Dr. Luis G. Echeverri, MD This Doctor is OpenDoctor Recommended.
	Dr. Garrett L. Walsh, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Gary B. Skakun, MD This Doctor is OpenDoctor Recommended.
	Dr. Phillip R. Adams, MD This Doctor is OpenDoctor Recommended.
	Dr. Mario O. Kapusta, MD
	Dr. Patricio E. Lau, MD
	Dr. Muhammad U. Jawad, MD
	Izu D. Okpara This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog